Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma.
about
Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinomaNeutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.CD8+ T-cell responses rapidly select for antigen-negative tumor cells in the prostate.Clinical implication of HLA class I expression in breast cancerThe bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key?HLA class I expression and its alteration by preoperative hyperthermo-chemoradiotherapy in patients with rectal cancer.A versatile technique for the in vivo imaging of human tumor xenografts using near-infrared fluorochrome-conjugated macromolecule probes.Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment.Immunology and Immunotherapy of Head and Neck CancerExpression of MHC Class I on breast cancer cells correlates inversely with HER2 expressionDown-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patientsChanging the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma.The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer.Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma.Immunologic biomarkers as correlates of clinical response to cancer immunotherapy.Immunotherapy for head and neck cancer: the future of treatment?Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options.Prognostic significance of HLA class I and II expression in patients with diffuse large B cell lymphoma treated with standard chemoimmunotherapy.Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma.Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I.Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma.Clinical implications of human leukocyte antigen class I expression in endometrial cancer.Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma.Expression of PD-L1 and HLA Class I in Esophageal Squamous Cell Carcinoma: Prognostic Factors for Patient Outcome.Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer.
P2860
Q28265651-A16A1FFB-116B-4C8A-A680-42B6298808CAQ33762053-12536D49-7869-402C-88AF-26D9BC12786BQ33931006-75606FA4-6EED-40BB-B309-D8AC5D57879AQ34052449-86BD7917-C3B5-4A6F-8583-ED3F9F922587Q34199253-B6F5BE07-A4BA-4E83-AF3C-AB9824D6733EQ34258479-57C5200E-9A4E-4EC3-AF3F-80556673A2A4Q35072877-F1B8A5DF-76C1-4CD6-BDC5-98D2FAE8BE78Q35713265-DE7A91D4-663F-452A-A459-D084B7AC35C6Q36100837-4DCAA609-246C-4F17-807E-D87E530D9374Q36388523-DB1282CC-1169-414B-A634-AC09D118E841Q36645793-C9EBCFEC-7698-4F43-A5F9-C6981A7540C7Q36849676-7DD551B3-E90E-42E0-9134-0FFB881C53E1Q37377808-7BCA2932-B726-4319-9986-FB776B74CA8EQ37703330-CA2B1707-C5B9-437F-9CB4-89272338D7EEQ37827418-810F1480-4390-49A3-B962-D547867757FEQ38736238-DD18C249-A23D-4A2F-8D9E-1932D3766057Q39308337-AB4B089D-166B-4648-80B5-5258205CD8BFQ39492021-20C923B3-8A0D-4A47-9E2F-10A32EE9979BQ39680556-33C1A816-F405-4A51-8D5D-FED40DAB0167Q41862292-0286D81E-7837-444B-BEB2-4702CC6E3808Q42112527-835B0A89-CF70-4782-B477-B070C43CDA71Q43147365-E9B68684-A568-43B0-B688-4DAF9A0C9368Q45061505-74A5D2AF-B96A-4F10-9B68-5F428BF6F630Q50788575-E2FC5841-5AB0-4ACD-A2F6-91084A018E34Q50960953-F95A087D-3F01-4C8D-A6A4-D82DF9D9CBA2
P2860
Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Downregulation of HLA Class I ...... ageal squamous cell carcinoma.
@en
type
label
Downregulation of HLA Class I ...... ageal squamous cell carcinoma.
@en
prefLabel
Downregulation of HLA Class I ...... ageal squamous cell carcinoma.
@en
P2093
P2860
P356
P1476
Downregulation of HLA Class I ...... ageal squamous cell carcinoma.
@en
P2093
K Kamimura
M Watanabe
T Maruyama
Y Kawaguchi
Y Mizukami
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604715
P407
P577
2008-10-07T00:00:00Z